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This case demonstratesthe potential role of oestro-
gens in the occurrence and relapse of bipolar
affective disorder, and pointers towards possible
treatment options. The case also demonstrates
the potential iatrogenic harm of hormonal
manipulation in a woman with a history of puerp-
eral psychosis.
Case report
This female patient is now 47 years old and works
as a ﬁtness instructor. She is married and has two
children and has no family history of psychiatric
disorder. She presented to Accident and Emer-
gency with ﬂorid symptoms of mania necessitat-
ing admission to a locked psychiatric ward
under the Mental Health Act. She was disinhib-
ited, garrulous, with ﬂight of ideas, sleep disturb-
ance and grandiosity. During her stay she
sustained an injury to her leg while jumping off
a bed.
Two days prior to her presentation she had been
administered intramuscularly the gonadotrophin-
releasing hormone antagonist (GnRH) analogue
leuproreline acetate. This was to reduce the vascu-
larity of endometrial ﬁbroids in preparation for
surgery.
The only past psychiatric history of note was
a very similar presentation of ﬂorid mania
14 years previously necessitating admission to a
psychiatric hospital under the Mental Health
Act. This was 5 days postpartum after her
second child and was described as a puerperal
psychosis, and from which she fully recovered
and had no need for long-term psychiatric
support or medication.
The patient was stabilized on Semi Sodium
Valproate 500 mg twice a day and Olanzapine
17.5 mg daily and had been discharged after 8
weeks euthymic. She subsequently went on to
have a hysterectomy with preservation of the
ovaries, and was discharged from psychiatric
follow-up 2 years later.
Five years later she was re-referred from her
general practitioner (GP). She had noticed early
warning signs and thought she may be relapsing.
She also noticed racing thoughts and an inability
to concentrate and had some sleep disturbance.
She was also suffering from hot sweats and was
biochemically menopausal. She was recom-
menced on Semi Sodium Valproate and decided
after discussion with her GP to commence
hormone replacement therapy (HRT). She has
subsequently made a full recovery, and is now
back at work and back to her ‘normal self’.
Discussion
This case is interesting in demonstrating a number
of aspects of the association between oestrogen
and psychosis. Her manic episodes have been
associated with three different mechanisms
where reduction in oestrogens are seen; post
natally, following a GnRH analogue, and
menopausally.
Deucher and Brockington
1 proposed a ‘unitary
etiological hypothesis’ linking cases of puerperal
psychosis and rare menstrual psychoses, where
psychotic episodes occur premenstrually and at a
time in the menstrual cycle where there is a
sharp fall in circulating oestrogens and progester-
one. The administration of the GnRH analogue
and the menopause as seen in this case could
also ﬁt into this unitary hypothesis.
Regarding the use of the GnRH analogue, the
data presented at the Drug Analysis Point on the
Medicines and healthcare products Regulatory
Agency website (www.mhra.gov.uk) have
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1recorded 23 incidents of psychiatric symptoms fol-
lowing administration of this drug. However, the
symptoms presented are non-speciﬁc with one
episode of ‘altered mood’ and two cases of
‘mood swings’. There is no further information
regarding these episodes. However, in a review
article, Durmaine et al.
2 quote four cases of psy-
chosis occurring after administration of Clomi-
phene and one case after administration of a
gonaderelin agonist, both drugs acting to reduce
oestrogens. Given this patient’s history of puerp-
eral psychosis, should there have been caution in
administering a GnRH analogue? This is a difﬁ-
cult question as the psychosis was 14 years pre-
viously. However, alternatives may have been
considered with the patient if this caution had
been picked up.
Menopausal changes associated with psychosis
have been less documented overall and indeed in
this case a full-blown psychosis did not occur.
There is a suggestion that the menopause is a
more gradual process and acute symptoms are
less inclined to occur.
1 Preserving the patient’s
ovaries was a way of avoiding a precipitous fall
in oestrogens until slower reductions start to take
place naturally. The issue of using HRT in an
attempt to avoid this reduction was certainly
helpful for this patient. However, a recent review
for the Cochrane Collaboration
3 revealed that
adjunctive oestrogens faired little better than
placebo. In addition, the health risks associated
with use of these drugs has to be weighed
against the unproven avoidance of severe mental
health symptoms. Ultimately this was a decision
the patient came to herself and will be for a
limited time. Cessation of these drugs may then
paradoxically increase the risks of a more severe
episode occurring in the future.
As regards the reported mechanisms by which
oestrogens affect mental health, there are a
number of reports in the literature. Oestrogen
blocks dopamine as shown by increases in prolac-
tin after they have been administered.
4 A
reduction in oestrogens could lead to a hyperdo-
paminergic state leading to psychosis.
5 However,
oestrogens have many complex mechanisms of
action in many brain regions ranging from
second messenger systems to effects on neuronal
excitability and ion channels and calcium homeo-
stasis, which in turn affect catecholaminergic and
serotonergic pathways.
6 These pathways and
others have been implicated in psychosis.
This case therefore demonstrates the vulner-
ability a woman may have throughout the repro-
ductive lifespan when a psychosis has occurred
which may be linked with falls in oestrogen.
This should be borne in mind when any exogen-
ous agent is proposed that may induce similar
hormonal changes.
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